Atlanta Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-22,338
Closed -$3.26M 171
2019
Q4
$3.26M Sell
22,338
-159
-0.7% -$21.6K 0.01% 157
2019
Q3
$2.91M Buy
22,497
+487
+2% +$64.2K 0.01% 154
2019
Q2
$3.07M Sell
22,010
-1,176
-5% -$163K 0.01% 156
2019
Q1
$3.24M Sell
23,186
-5,149
-18% -$690K 0.02% 153
2018
Q4
$3.66M Sell
28,335
-2,614
-8% -$365K 0.02% 150
2018
Q3
$4.28M Sell
30,949
-2,927
-9% -$389K 0.02% 146
2018
Q2
$4.11M Sell
33,876
-417,207
-92% -$52.1M 0.02% 143
2018
Q1
$57.8M Buy
451,083
+175
+0% +$23.7K 0.3% 78
2017
Q4
$63M Buy
450,908
+61,687
+16% +$8.59M 0.33% 72
2017
Q3
$50.6M Buy
389,221
+106,622
+38% +$14.1M 0.29% 75
2017
Q2
$37.4M Buy
282,599
+43,859
+18% +$5.59M 0.22% 94
2017
Q1
$29.7M Buy
+238,740
New +$28.5M 0.18% 115

Other funds holding JNJ

Atlanta Capital Management's JNJ Position: Q1 2020 in Review

Atlanta Capital Management sold out of Johnson & Johnson (JNJ) in Q1 2020, closing a stake of 22,338 shares — an estimated $3.26M sold.

Atlanta Capital Management first reported a position in JNJ in Q1 2017 and held it in 12 quarters. The position peaked at $63M in Q4 2017. 2,932 funds tracked by Wall St. Rank hold JNJ as of Q1 2020.

  • Atlanta Capital Management reported no remaining Johnson & Johnson position as of Q1 2020 after selling out during the quarter.
  • Atlanta Capital Management sold 22,338 Johnson & Johnson shares in Q1 2020, an estimated $3.26M.
  • Atlanta Capital Management first reported a position in Johnson & Johnson in Q1 2017 and held it in 12 quarters.
  • Atlanta Capital Management's Johnson & Johnson position peaked at $63M in Q4 2017.
  • 2,932 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2020.

Based on Atlanta Capital Management's 13F filing for Q1 2020, filed 12 May 2020.